Bank of America’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-316,856
| Closed | -$2.86M | – | 6901 |
|
|
2025
Q4 | $2.86M | Sell |
316,856
-212,393
| -40% | -$1.59M | ﹤0.01% | 3789 |
|
|
2025
Q3 | $1.65M | Sell |
529,249
-309,138
| -37% | -$819K | ﹤0.01% | 4977 |
|
|
2025
Q2 | $1.79M | Sell |
838,387
-178,262
| -18% | -$288K | ﹤0.01% | 4870 |
|
|
2025
Q1 | $1.17M | Sell |
1,016,649
-3,256,793
| -76% | -$5.59M | ﹤0.01% | 5115 |
|
|
2024
Q4 | $9.36M | Buy |
4,273,442
+3,376,446
| +376% | +$7.65M | ﹤0.01% | 3015 |
|
|
2024
Q3 | $1.96M | Buy |
896,996
+483,862
| +117% | +$1.11M | ﹤0.01% | 4579 |
|
|
2024
Q2 | $954K | Buy |
413,134
+109,894
| +36% | +$457K | ﹤0.01% | 4932 |
|
|
2024
Q1 | $1.67M | Buy |
303,240
+251,356
| +484% | +$1.15M | ﹤0.01% | 4568 |
|
|
2023
Q4 | $128K | Buy |
51,884
+3,912
| +8% | +$37.2K | ﹤0.01% | 6277 |
|
|
2023
Q3 | $1.67M | Sell |
47,972
-22,215
| -32% | -$768K | ﹤0.01% | 4432 |
|
|
2023
Q2 | $2.3M | Sell |
70,187
-7,491
| -10% | -$258K | ﹤0.01% | 4105 |
|
|
2023
Q1 | $2.6M | Buy |
77,678
+23,948
| +45% | +$931K | ﹤0.01% | 4109 |
|
|
2022
Q4 | $1.76M | Buy |
53,730
+42,965
| +399% | +$1.27M | ﹤0.01% | 4366 |
|
|
2022
Q3 | $375K | Sell |
10,765
-5,198
| -33% | -$115K | ﹤0.01% | 5599 |
|
|
2022
Q2 | $195K | Sell |
15,963
-14,717
| -48% | -$220K | ﹤0.01% | 6119 |
|
|
2022
Q1 | $416K | Sell |
30,680
-16,247
| -35% | -$217K | ﹤0.01% | 5961 |
|
|
2021
Q4 | $932K | Buy |
+46,927
| New | +$889K | ﹤0.01% | 5357 |
|
Other funds holding VTYX
Bank of America's VTYX Position: Q1 2026 in Review
Bank of America sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 316,856 shares — an estimated $2.86M sold.
Bank of America first reported a position in VTYX in Q4 2021 and held it in 17 quarters. The position peaked at $9.36M in Q4 2024. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.
- Bank of America reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 316,856 Ventyx Biosciences shares in Q1 2026, an estimated $2.86M.
- Bank of America first reported a position in Ventyx Biosciences in Q4 2021 and held it in 17 quarters.
- Bank of America's Ventyx Biosciences position peaked at $9.36M in Q4 2024.
- 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.